Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Call for Submissions 2018 – US Ophthalmic Review, 2017;10(2):85

Elizabeth Yeu
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Oct 31st 2017 US Ophthalmic Review, 2017;10(2):85 DOI: https://doi.org/10.17925/USOR.2017.10.02.85
Select a Section…
1

Article

Dear Colleagues

The US Ophthalmic Review welcomes colleagues in the ophthalmology community to contribute
articles to the Spring and Fall 2018 editions. The journal is dedicated to the publication of
topical articles that provide practical guidance and advice to practising physicians.

We welcome authors to submit original research, review articles, case reports, and editorials
across all areas of ophthalmology, for consideration. We are particularly interested in reports of
real-world studies, along with concise review articles that translate the latest clinical trial data
and developments in the field for busy physicians. Authors can submit their manuscript through
the Editorial Manager site (details below) and the journal’s editor is happy to receive any presubmission
enquiries. Accepted articles are published open access, both in print and online, and
we encourage authors to publish accompanying multimedia content alongside the article.

We look forward to working with you.

Elizabeth Yeu and the US Ophthalmic Review Team

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup